Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
52
MTZ Quote, Financials, Valuation and Earnings
Last price:
$176.56
Seasonality move
:
-1.27%
Day range:
$171.15 - $175.11
52-week range:
$89.96 - $175.11
Dividend yield:
0%
P/E ratio:
64.10x
P/S ratio:
1.10x
P/B ratio:
4.77x
Volume:
1.1M
Avg. volume:
799.7K
1-year change:
63.98%
Market cap:
$13.8B
Revenue:
$12.3B
EPS (TTM):
$2.72
Analysts' Opinion
-
Consensus RatingMasTec has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $178.81, MasTec has an estimated upside of 2.55% from its current price of $174.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $128.00 representing 26.59% downside risk from its current price of $174.36.
Fair Value
-
According to the consensus of 15 analysts, MasTec has 2.55% upside to fair value with a price target of $178.81 per share.
MTZ vs. S&P 500
-
Over the past 5 trading days, MasTec has overperformed the S&P 500 by 2.91% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MasTec does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MasTec has grown year-over-year revenues for 2 quarters straight. In the most recent quarter MasTec reported revenues of $2.8B.
Earnings Growth
-
MasTec has grown year-over-year earnings for 3 quarters straight. In the most recent quarter MasTec reported earnings per share of $0.13.
Enterprise value:
15.7B
EV / Invested capital:
--
Price / LTM sales:
1.10x
EV / EBIT:
32.36x
EV / Revenue:
1.26x
PEG ratio (5yr expected):
--
EV / Free cash flow:
17.05x
Price / Operating cash flow:
14.94x
Enterprise value / EBITDA:
16.37x
Gross Profit (TTM):
$1.6B
Return On Assets:
2.43%
Net Income Margin (TTM):
1.72%
Return On Equity:
7.53%
Return On Invested Capital:
4.07%
Operating Margin:
1.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $10.4B | $12.1B | $12.5B | $2.7B | $2.8B | |
| Gross Profit | $1.2B | $1.5B | $1.6B | $307.2M | $311.1M | |
| Operating Income | $72.3M | $168.6M | $471.9M | $515K | $36.1M | |
| EBITDA | $660.4M | $825.9M | $960M | $147.6M | $156.8M | |
| Diluted EPS | -$0.16 | -$0.14 | $2.72 | -$0.53 | $0.13 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.6B | $2.8B | $3.7B | $3.4B | $3.5B | |
| Total Assets | $5.5B | $7.1B | $9.1B | $8.7B | $8.9B | |
| Current Liabilities | $1.6B | $1.9B | $2.4B | $2.6B | $2.9B | |
| Total Liabilities | $3.4B | $4.6B | $6.4B | $6.1B | $5.9B | |
| Total Equity | $2.1B | $2.5B | $2.6B | $2.7B | $3B | |
| Total Debt | $1.3B | $1.9B | $3.2B | $2.7B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $134.4M | $881.4M | $1.1B | $107.8M | $78.4M | |
| Cash From Investing | -$809.3M | -$101.6M | -$179.4M | -$13M | -$34.9M | |
| Cash From Financing | $585.5M | -$672.4M | -$813.1M | -$374.8M | -$97.7M | |
| Free Cash Flow | -$109.1M | $726.4M | $921.5M | $82.3M | $31.1M | |
MTZ
Sector
Market Cap
$13.8B
$611.3M
Price % of 52-Week High
99.57%
81.21%
Dividend Yield
0%
0%
Shareholder Yield
--
2.28%
1-Year Price Total Return
63.98%
-1.12%
Beta (5-Year)
1.749
0.761
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$170.90
200-day SMA
Buy
Level
$139.32
Bollinger Bands (100)
Buy
Level
120.48 - 162.7
Chaikin Money Flow
Buy
Level
1.9M
20-day SMA
Buy
Level
$169.25
Relative Strength Index (RSI14)
Buy
Level
66.83
ADX Line
Sell
Level
23.82
Williams %R
Sell
Level
-6.8244
50-day SMA
Buy
Level
$161.22
MACD (12, 26)
Buy
Level
46.93
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
280.7K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0634)
Sell
CA Score
(Annual)
Level (-0.6097)
Buy
Beneish M-Score
(Annual)
Level (-2.9526)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.2182)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company’s primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
Stock Forecast FAQ
In the current month, MTZ has received 12 Buy ratings 3 Hold ratings, and 0 Sell ratings. The MTZ average analyst price target in the past 3 months is $178.81.
-
Where Will MasTec Stock Be In 1 Year?
According to analysts, the consensus estimate is that MasTec share price will rise to $178.81 per share over the next 12 months.
-
What Do Analysts Say About MasTec?
Analysts are divided on their view about MasTec share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MasTec is a Sell and believe this share price will drop from its current level to $128.00.
-
What Is MasTec's Price Target?
The price target for MasTec over the next 1-year time period is forecast to be $178.81 according to 15 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is MTZ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MasTec is a Buy. 12 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MTZ?
You can purchase shares of MasTec via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MasTec shares.
-
What Is The MasTec Share Price Today?
MasTec was last trading at $176.56 per share. This represents the most recent stock quote for MasTec. Yesterday, MasTec closed at $174.36 per share.
-
How To Buy MasTec Stock Online?
In order to purchase MasTec stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
